Bullfrog AI Holdings, Inc. (BFAI)

Bullfrog AI Holdings will go public soon. The estimated IPO date is December 9, 2022.
IPO Price
$6.38
Shares Offered
1,317,647
Deal Size
$8,406,588

Company Description

Bullfrog AI Holdings uses artificial intelligence and machine learning to advance medicines for both internal and external projects.

We are committed to increasing the probability of success and decreasing the time and cost involved in developing therapeutics.

Our platform technology, named, bfLEAP™, is an analytical AI/ML platform derived from technology developed at The Johns Hopkins University Applied Physics Laboratory (JHU-APL), which is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise, multi-dimensional understanding of their data.

The bfLEAP™ platform utilizes both supervised and unsupervised machine learning – as such, it is able to reveal real/meaningful connections in the data without the need for a prior hypothesis.

We are deploying bfLEAP™ for use at several critical stages of development for internal programs and through strategic partnerships and collaborations with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may otherwise not receive the therapies they need.

Bullfrog AI Holdings, Inc.
Country United States
Founded 2017
IPO Date Dec 9, 2022
Industry Health Care
Sector Biotechnology
Employees 2
CEO Vininder Singh

Contact Details

Address:
323 Ellington Blvd, Unit 317
Gaithersburg, MD 20878
United States
Phone (240) 658-6710
Website bullfrogai.com

Stock Details

Ticker Symbol BFAI
Exchange NASDAQ
Reporting Currency USD
IPO Price $6.38
CIK Code 0001829247
Employer ID 84-4786155
SIC Code 2834

Key Executives

Name Position
Vin Singh Chief Executive Officer and Director
Dane Saglio Chief Financial Officer
Don Elsey Director, Chair Audit Committee
William Enright Director and Chair of Compensation Committee
Jason Hanson Director and Chair of Nominating and Corporate Governance Committee

Latest SEC Filings

Date Type Title
Nov 28, 2022 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 7, 2022 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Oct 19, 2022 S-1 General form for registration of securities under the Securities Act of 1933
Aug 15, 2022 DRS/A [Amend] [Cover] Draft Registration Statement
Jun 10, 2022 DRS [Cover] Draft Registration Statement
May 12, 2022 D Notice of Exempt Offering of Securities
Dec 14, 2020 C/A Filing
Nov 27, 2020 C/A Filing
Oct 27, 2020 C/A Filing
Oct 22, 2020 C Filing